
|Articles|May 1, 2004
Integrated analysis underlines etanercept efficacy in psoriasis
Washington - Results of a multistudy analysis reinforce the efficacy of subcutaneous etanercept (Enbrel, Amgen) for inducing rapid and sustained improvement in patients with chronic plaque psoriasis, said Kenneth Gordon, M.D., at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Dupilumab Demonstrates Positive Effects on TCS Use, Growth in Pediatric Patients
2
Arcutis Completes Enrollment in Phase 2 Study of Roflumilast Cream for Infant AD
3
Pilot Study Tests Oral NAC as Adjunct in Vitiligo Therapy
4
Previewing the 2025 Elevate-Derm Fall Conference
5



















